Most patients in Thailand experience mild, temporary reactions. These include injection site redness, low-grade fever, or fatigue. These symptoms usually resolve within 48 hours. Accredited facilities using Good Manufacturing Practice (GMP) standards report low adverse event rates. Systemic risks like immune rejection, infection, or vascular blockages depend on clinic certification and cell processing quality.
- Injection reactions: Mild pain, swelling, or bruising at the site of the IV or local injection.
- Immune response: Low-grade fever, chills, or headaches as the body reacts to the cellular therapy.
- Vascular safety: Blockages or blood clots if IV infusions are administered at an incorrect speed.
- Regulatory risks: Severe complications may occur at uncertified clinics using poorly screened donor cell lines.
Bookimed Expert Insight: Many clinics offer outpatient drips. However, the safest approach involves facilities like Plenary Wellness or ID Clinic. These centres include medical supervision and 24-hour post-op care. They often perform 1,000+ procedures annually. This experience helps clinicians quickly identify and manage rare systemic inflammatory responses.
Patient Consensus: Patients in Thailand report short-term flu-like symptoms and local swelling most frequently. Many suggest asking for sterility documentation. They also recommend confirming if telehealth follow-up is available before returning to Australia.